Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|May 20, 2020
The role of PPARα in autosomal dominant polycystic kidney diseaseRonak Lakhia
The Journal of Clinical Investigation|June 16, 2025
Uromodulin modulates mitochondria and kidney tubule resilienceRonak Lakhia, Chunzi Song, Vishal Patel
Methods in Cell Biology|September 9, 2019
Manipulation of renal gene expression using oligonucleotidesRonak Lakhia, Abheepsa Mishra, Vishal Patel
BMJ Case Reports|October 23, 2012
Surviving the storm: two cases of thyroid storm successfully treated with plasmapheresisAubrey Carhill, Absalon Gutierrez, Ronak Lakhia, et al.
Scientific Reports|February 15, 2019
Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growthMatanel Yheskel, Ronak Lakhia, Patricia Cobo-Stark, et al.
Molecular and Biochemical Parasitology|June 23, 2007
The role of DNA mismatch repair in generating genetic diversity and drug resistance in malaria parasitesLara Bethke, Susan Thomas, Kerone Walker, et al.
Kidney International|October 25, 2022
Enhancer and super-enhancer landscape in polycystic kidney diseaseRonak Lakhia, Abheepsa Mishra, Laurence Biggers, et al.
American Journal of Physiology. Renal Physiology|September 15, 2017
PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in miceRonak Lakhia, Matanel Yheskel, Andrea Flaten, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 6, 2013
Interactions between p-Akt and Smad3 in injured muscles initiate myogenesis or fibrogenesisYanjun Dong, Ronak Lakhia, Sandhya S Thomas, et al.
Nucleic Acids Research|January 20, 2026
Disruption of a six-nucleotide miRNA motif improves PKD1 dosage and ameliorates polycystic kidney diseaseRonak Lakhia, Chunzi Song, Laurence Biggers, et al.
Pageof 2